Fidia S.p.A. (BIT:FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 1.95M |
| Revenue (ttm) | 21.13M |
| Net Income (ttm) | -2.19M |
| Shares Out | 14.90M |
| EPS (ttm) | -1.15 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,254,530 |
| Average Volume | 1,260,959 |
| Open | 0.1333 |
| Previous Close | 0.1327 |
| Day's Range | 0.1300 - 0.1379 |
| 52-Week Range | 0.1260 - 9.3800 |
| Beta | -0.03 |
| RSI | 28.63 |
| Earnings Date | Nov 14, 2025 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
Financial Performance
In 2024, Fidia's revenue was 17.53 million, a decrease of -38.98% compared to the previous year's 28.74 million. Losses were -9.30 million, 611.4% more than in 2023.
Financial StatementsNews
Praxis' Epilepsy Drug Too Good To Continue, FDA Meeting Up Next
Praxis Precision Medicines Inc . (NASDAQ: PRAX) stock rose Friday after the company shared results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patie...
Crude Oil Moves Higher; Domo Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Friday. The Dow traded up 0.17% to 47,933.71 while the NASDAQ rose 0.16% to 23,543.03. The S&P 500 al...
Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start
FDA placed hold on Denali's drug ... Full story available on Benzinga.com
FDA Warns Against Abbott Glucose Monitor Sensors After Reports Of Over 700 Injuries, 7 Deaths
FDA warns that certain FreeStyle Libre 3 ... Full story available on Benzinga.com
ServiceTitan Posts Upbeat Q3 Results, Joins DigitalBridge, Rubrik, Victoria's Secret And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones gaining more than 150 points on Friday. Shares of ServiceTitan Inc (NASDAQ: TTAN) rose sharply during Friday's session after the company reported better-th...
PolyPid Clears a Key FDA Milestone, Reducing Regulatory Risk Ahead of Its Planned NDA Filing ...
PolyPid Clears a Key FDA Milestone, Reducing Regulatory Risk Ahead of Its Planned NDA Filing (NASDAQ: PYPD)
Bristol Myers' Cancer Breakthrough Breyanzi Just Won Its Fifth FDA Approval
On Thursday, the U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb & Co.’s (NYSE: BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CA...
Milestone Pharma Prepares For FDA Decision On CARDAMYST, Stock In Focus
(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) is awaiting a pivotal U.S. FDA decision this month on the company's lead drug candidate, CARDAMYST nasal spray, for the acute treatment of paroxysmal ...
Praxis Precision Medicines Stock Surges 25% In Friday Pre-Market Trading— What's Going On?
Praxis Precision Medicines Inc. (NASDAQ: PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here . PRAX closed Thursday's regul...
Ascentage Gets Regulatory Clearance In The US And Europe To Conduct POLARIS-1 Trial
(RTTNews) - Suzhou, China-based Ascentage Pharma Group International (AAPG, 6855.HK) announced that the FDA and the European Medicines Agency have given clearance to conduct a global registrational Ph...
Ascentage Pharma To Launch Global Phase III Study Of Olverembatinib In Ph+ ALL
(RTTNews) - Ascentage Pharma Group International (AAPG, 6855.HK) announced that it received clearance from both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to lau...
FDA Removes Partial Clinical Hold On Tradipitant For Motion Sickness
(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) announced on Thursday that the U.S. FDA has lifted the partial clinical hold on its motion sickness protocol, VP-VLY-686-3403, for Tradipitant, which had ...
FDA Approves Bristol Myers' Breyanzi For Relapsed/Refractory Marginal Zone Lymphoma
(RTTNews) - Bristol Myers Squibb (BMY) today announced that the FDA has expanded Breyanzi's approval to include treatment of relapsed or refractory (R/R) marginal zone lymphoma in adult patients who h...
Glucose monitor problems linked with deaths, injuries: FDA
The FDA issued an “early alert” that some FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices may provide incorrect low glucose readings.
FDA Approves Bristol Myers Squibb's Breyanzi As First CAR T Therapy For R/R Marginal Zone Lymphoma
(RTTNews) - Bristol Myers Squibb (BMY) announced that the U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) ...
Bristol Myers (BMY) Receives FDA Approval for New Cancer Therapy
Bristol Myers (BMY) Receives FDA Approval for New Cancer Therapy
Merck Unit Gets FDA Conditional Approval For EXZOLT CATTLE-CA1 To Treat Key Cattle Parasites
(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc.(MRK), announced that the U.S. Food and Drug Administration has granted conditional approval for EXZOLT CATTLE-CA1 (fluralaner topical s...
Vanda Pharmaceuticals (VNDA) Soars After FDA Lifts Tradipitant Hold
Vanda Pharmaceuticals (VNDA) Soars After FDA Lifts Tradipitant Hold
FDA could revamp drug approval
CNBC's Annika Kim Constantino joins 'Closing Bell Overtime' to talk changes coming out of the CDC and FDA.
Vanda jumps as FDA lifts tradipitant partial clinical hold
FDA Lifts Hold on Vanda Pharmaceuticals' (VNDA) Tradipitant Study
FDA Lifts Hold on Vanda Pharmaceuticals' (VNDA) Tradipitant Study
Charles River Laboratories (CRL) Stock Declines Amid FDA Announcement
Charles River Laboratories (CRL) Stock Declines Amid FDA Announcement
FDA Issues Warning on Abbott (ABT) Glucose Monitors After Reported Deaths
FDA Issues Warning on Abbott (ABT) Glucose Monitors After Reported Deaths